What You Should Know: – Philips IntelliSite Pathology 5.1 has received 510(k) clearance from the FDA, solidifying its position as the most widely deployed digital pathology solution for primary diagnosis globally. – With over…
Continue Reading
Introduction
Lantheus Holdings, Inc., a renowned radiopharmaceutical-focused company, has made a significant stride in the cancer care sector by acquiring the global rights to Life Molecular Imaging’s RM2. This novel therapeutic and diagnostic pair targets…
Introduction
Artificial Intelligence (AI) continues to revolutionize the medical field, offering unprecedented advancements in diagnostics and treatment. A new study by Avenda Health, published in The Journal of Urology, demonstrates AI’s remarkable capability to enhance…
What You Should Know:
– Color Health, a leader in comprehensive cancer care, and Carrum Health, known for their value-based cancer treatment programs form a startegic partnership to offer employers an end-to-end cancer program.
– By…
Continue Reading
What You Should Know:
– Cancer – the second leading cause of death in the United States – is a complex disease requiring timely diagnosis and treatment. Delays in either can significantly impact patient outcomes.
–…
Continue Reading
What You Should Know:
– Health Catalyst, a leading provider of data and analytics solutions for healthcare organizations, has finalized its acquisition of Carevive Systems.
– Carevive is a prominent oncology-focused health technology company dedicated to…
Continue Reading
What You Should Know:
– Color Health, a leader in comprehensive cancer care, announced today that it is partnering with SkinIO and Bexa to integrate their innovative solutions for skin and breast cancer screening into…
Continue Reading
What You Should Know:
– Thyme Care, a leader in value-based cancer care, has announced a strategic investment from Echo Health Ventures and CVS Health Ventures. Both partners have identified Thyme Care’s provider-centric approach as…
Continue Reading
UK digital cancer care platform Careology has partnered with the US’s Evolent Health with the aim of delivering more coordinated, connected care pathways for US health plan patients.The partnership between the public and private…
Continue Reading
The following is a guest article by Dr. Daniel Vorobiof, Chief Medical Director at Belong.Life
The integration of artificial intelligence (AI) in oncology care has allowed for unprecedented levels of support and guidance for cancer…
